Lv21
128 积分 2024-01-23 加入
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
11小时前
已完结
Population pharmacokinetics and clinical outcomes of polymyxin B in paediatric patients with multidrug-resistant Gram-negative bacterial infections
4个月前
已完结
Pharmacokinetics of polymyxin B in different populations: a systematic review
4个月前
已完结
Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation
4个月前
已完结
Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections
4个月前
已完结
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
4个月前
已完结
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects
4个月前
已完结
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients
5个月前
已完结
The Determination of Polymyxin B in Critically Ill Patients by the HPLC-MS/MS Method
5个月前
已完结
A simple HPLC–MS/MS method for the determination of polymyxin B in human plasma and its application in the pharmacokinetic study in elderly patients infected with multidrug-resistant Gram-negative bacteria
5个月前
已完结
皖公网安备34019202002308
